NCT05907954 2026-03-16(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular MelanomaIDEAYA BiosciencesPhase 2 Active not recruiting160 enrolled
NCT01490632 2019-09-27A Phase 2b Study of Baricitinib in Participants With Moderate to Severe PsoriasisEli Lilly and CompanyPhase 2 Completed271 enrolled 32 charts
NCT02634931 2019-02-20Long-term Trial of Topical Sirolimus to Angiofibroma in Patient With Tuberous Sclerosis ComplexNobelpharmaPhase 3 Completed94 enrolled
NCT01241591 2018-12-26A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque PsoriasisPfizerPhase 3 Completed1,101 enrolled 46 charts
NCT02635789 2017-02-02Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Complex (TSC)NobelpharmaPhase 3 Completed62 enrolled